Journal
JOURNAL OF NATURAL PRODUCTS
Volume 73, Issue 3, Pages 383-387Publisher
AMER CHEMICAL SOC
DOI: 10.1021/np900281r
Keywords
-
Funding
- NCRR NIH HHS [C06 RR1450301, P20 RR021929] Funding Source: Medline
- NIAID NIH HHS [R01 AI027094, AI 27094, 2P30-AI050409, R-01 AI 36596-12, P30 AI050409, R01 AI036596] Funding Source: Medline
- NCPDCID CDC HHS [U01 CI000211, U01/CI000211] Funding Source: Medline
Ask authors/readers for more resources
Bioassay- and LC-MS-guided fractionation of a methanol extract from a new, deep-water Alaskan sponge species of the genus Latrunculia resulted in the isolation of two new, brominated pyrroloiminoquinones, dihydrodiscorhabdin 11 (1) and discorhabdin Y (2), along with six known pyrroloiminoquinone alkaloids, discorhabdins A (3), C (4), E (5), and L (6), dihydrodiscorhabdin C (7), and (lie benzene derivative 8. Compounds 3, 4, and 7 exhibited anti-HCV activity, antimalarial activity, and selective antimicrobial activity. Although compounds 3 and 7 displayed potent and selective ill vitro antiprotozoal activity, Plasmodium berghei-infected mice did not respond to these metabolites clue to their toxicity in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available